Gender, age, smoking, tumor size, TNM stage, microvascular invasion, Ki67, adjuvant therapy, PLT, PLT2, and PPR were significant prognostic factors for affecting the patients with NSCLC (Table 2 and 3). The gene discussed is MKI67; the disease is non-small cell lung carcinoma.